In cancers where aberrantly reactivated, SALL4 has been associated with the expression of many stemness-related genes (i.e. OCT4, NANOG, c-Myc, and SOX2) conferring to the cancer cells self-renewal pluripotency abilities [3]. This evidence concerns the gene MYC and cancer.